Linked Life Data

2396416

Source:http://linkedlifedata.com/resource/pubmed/id/2396416

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1990-10-11
pubmed:abstractText
56 patients, aged from 28 up to 60 years, with ischemic heart disease II-III functional class according to the Canadian classification were treated with the original Hungarian drug Sensit in out-patient conditions. The number of patients with anginal pain fell from 56 to 12 and the overall effect of the Sensit treatment was 84% (47 patients improved). The physical load tolerance significantly increased--from 58.2 to 67.4 W. Sensit influences the pathological ECG changes--ST segment lowering after physical load. It must be emphasized that the effect of the Sensit treatment is seen after a 3 week course of treatment at least. The drug is suitable for an out-patient treatment.
pubmed:language
bul
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0506-2772
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-8
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
[Outpatient polyclinic observations on senzit in the treatment of ischemic heart disease].
pubmed:publicationType
Journal Article, English Abstract